Private Market View

RayzeBio

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$372.8M
Last round
Later Stage VC (Series D)
Sep 2022
Investors — not yet on record

No investors in RayzeBio are on record yet. Backers surface from round announcements, filings, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 4 rounds
  • ·Watchlist + deal alerts for RayzeBio
Create free account
No card required